HyQure Will Be At CPHI Milan 2026 From 6–8 October

At CPHI Milan, our team will be available to discuss your current development programs, biosafety testing strategies and regulatory testing requirements.

Our Key Capabilities:

● Viral Clearance Studies

● Cell Line Characterization

● RCL / RCR / rcAAV Testing

● GMP Lot Release & Stability Testing

● Biosafety Support for IND / CTA / BLA Programs

Whether you are developing biologics, vaccines, viral vectors, cell therapies or other advanced therapies, we look forward to discussing how HyQure can support your development and regulatory milestones.